Sanofi SA
Company Profile
Business description
Sanofi develops and markets drugs with a concentration in oncology, immunology, cardiovascular disease, diabetes, over-the-counter treatments and vaccines. However, the company's decision in late 2019 to pull back from the cardio-metabolic area will likely reduce the firm's footprint in this large therapeutic area. The company offers a diverse array of drugs with its highest revenue generator, Dupixent, representing just over 20% of total sales, but profits are shared with Regeneron. About 40% of total revenue comes from the United States and 25% from Europe. Emerging markets represent the majority of the remainder of revenue.
Contact
46, avenue de la Grande Armée
Paris 75017
FRAT: +33 153774000
E: investor.relations@sanofi.com
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - General
Fiscal Year End
31 December 2024
Employees
87,994
Sanofi SA News & Analysis
stocks
Magnificent Seven vs. the ‘Granolas’: How does Europe’s version stack up?
stocks
10 best US blue-chip shares to buy for the long term
personal-finance
Can you achieve global diversification with multinational companies?
Morningstar Investment Ideas
Stocks
ETFs
- Australian ETFs
- Active Australian Equity ETFs
- Passive Australian Equity ETFs
- Emerging Market Equity ETFs
- Sustainable ETFs
- Active Global Equity ETFs
- Passive Global Equity ETFs
- Active Australian Fixed Interest ETFs
- Passive Australian Fixed Interest ETFs
- Active Australian Listed Property ETFs
- Passive Australian Listed Property ETFs
- Active Global Fixed Interest ETFs
- Passive Global Fixed Interest ETFs
- Active Global Infrastructure ETFs
- Passive Global Infrastructure ETFs
- Active Global Property ETFs
- Passive Global Property ETFs
Funds
- Active Australian Equity Funds
- Passive Australian Equity Funds
- Active Global Equity Funds
- Passive Global Equity Funds
- Sustainable Funds
- Emerging Market Equity Funds
- Passive Australian Listed Property Funds
- Active Australian Listed Property Funds
- Passive Global Infrastructure Funds
- Active Global Infrastructure Funds
- Active Global Property Funds
- Passive Global Property Funds
- Active Australian Fixed Interest Funds
- Passive Australian Fixed Interest Funds
- Active Global Fixed Interest Funds
- Passive Global Fixed Interest Funds
Markets
Index
|
Last price
|
Change
|
% Change
|
|---|---|---|---|
| All Ordinaries | 8,132.10 | 49.80 | 0.62% |
| CAC 40 | 8,220.10 | 52.60 | 0.64% |
| DAX 40 | 18,801.30 | 96.88 | 0.52% |
| Dow JONES (US) | 40,003.59 | 134.21 | 0.34% |
| FTSE 100 | 8,431.89 | 11.63 | 0.14% |
| HKSE | 19,636.22 | 82.61 | 0.42% |
| NASDAQ | 16,685.97 | 12.35 | -0.07% |
| Nikkei 225 | 39,069.68 | 282.30 | 0.73% |
| NZX 50 Index | 11,735.71 | 35.92 | 0.31% |
| S&P 500 | 5,303.27 | 6.17 | 0.12% |
| S&P/ASX 200 | 7,863.70 | 49.30 | 0.63% |
| SSE Composite Index | 3,171.15 | 17.12 | 0.54% |
Market Movers
Name
|
Last price
|
Change
|
% Change
|
|---|---|---|---|
| Sayona Mining Ltd SYA | 0.05 | 0.00 | -7.55% |
| The Star Entertainment Group Ltd SGR | 0.54 | 0.09 | 20.00% |
| Peninsula Energy Ltd PEN | 0.12 | 0.01 | 7.14% |
| Imugene Ltd IMU | 0.07 | 0.00 | -4.17% |
| South32 Ltd S32 | 3.89 | 0.13 | 3.46% |
| Silver Mines Ltd SVL | 0.22 | 0.03 | 13.16% |
| Telstra Group Ltd TLS | 3.67 | 0.00 | 0.00% |
| Alligator Energy Ltd AGE | 0.07 | 0.01 | 8.33% |
| Pilbara Minerals Ltd PLS | 4.20 | 0.10 | 2.44% |
| De Grey Mining Ltd DEG | 1.20 | 0.04 | 3.00% |